Robert A. Krance

Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

Antonio Di Stasi, Siok‐Keen Tey, Gianpietro Dotti et al. · New England Journal of Medicine · 2011 · 1.5K citations · Full text

Life Sciences, Biotechnology, Immunology +13

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

Cliona M. Rooney, Catherine Y. Ng, Susan K. Loftin et al. · The Lancet · 1995 · 1.2K citations

Life Sciences, Genetics, Immunology +13

Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients

Cliona M. Rooney, Colton A. Smith, Catherine Y. Ng et al. · Blood · 1998 · 1.1K citations

Life Sciences, Immunology, Oncology +15

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

Amar Gajjar, Murali Chintagumpala, David M. Ashley et al. · The Lancet Oncology · 2006 · 949 citations · Full text

Medicine, Oncology, Pediatrics +17

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation

Malcolm K. Brenner, D. Rill, Robert A. Krance et al. · The Lancet · 1993 · 920 citations

Medicine, Cell Biology, Hematology +10